Search - tctmd.com

Displaying 541 - 560 of 999

Sort: Relevancy | Date

News Daily News

Cardiac Injury in COVID-19 Sharply Increases Risk of Death

Caitlin E. Cox

March 26, 2020

News Conference News ACC 2020

Hypertension-Related CV Deaths Surging Across the US

L.A. McKeown

March 24, 2020

News Daily News ACC 2020

Mental Stress-Induced Ischemia Increases Risk of Poor Outcomes Post-MI

Michael O'Riordan

March 23, 2020

News Daily News

Potent Antithrombotic Therapy Cuts Spontaneous MI After PCI for ACS

Yael L. Maxwell

March 10, 2020

News Daily News

Habitual Use of Fish Oil Prevents CVD, Real-world Data Suggest

Todd Neale

March 05, 2020

News Daily News

Type 2 MI Linked to More CV Deaths, Even in Younger Patients

Shelley Wood

March 04, 2020

News Daily News

Poor Sleepers at Higher Risk of CVD, MESA Data Suggest

Caitlin E. Cox

March 04, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2020

Shelley Wood

March 02, 2020

News Daily News

Meta-analysis Questions PCI vs CABG in Women With Multivessel Disease

Shelley Wood

February 27, 2020

News Daily News

Acute MI Symptom Clustering Differs in Men and Women: VIRGO

Michael O'Riordan

February 21, 2020

News Daily News

Outcome Differences Between Men and Women With PAD: EUCLID Insights

L.A. McKeown

February 11, 2020

News Daily News

Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis

Michael O'Riordan

February 10, 2020

News Daily News

Trials of New Cancer Drugs Failing to Address Potential CV Risks

Todd Neale

February 10, 2020

Presentation

Association of Sex With Outcomes in Patients Undergoing PCI

January 31, 2020

News Daily News

Clopidogrel Interaction With Morphine in ACS Linked to More Ischemic Events

Shelley Wood

January 20, 2020

News Daily News

Revascularization After PCI or CABG Linked to Higher Mortality: EXCEL

Michael O'Riordan

January 17, 2020

News Daily News

Pricey, Unproven ‘Executive’ CVD Screening the Norm at Top US Hospitals

Michael O'Riordan

January 16, 2020

News Daily News

Lp(a) Reduction Contributes to Alirocumab’s Treatment Benefit: ODYSSEY Outcomes

Michael O'Riordan

January 14, 2020

News Daily News

CV Safety Trial for Lorcaserin Picks Up Cancer Signal: FDA

Shelley Wood

January 14, 2020

News Daily News

Survey Reveals Troubling Unawareness of Common MI Symptoms

L.A. McKeown

December 19, 2019

Advertisement

Cardiac Injury in COVID-19 Sharply Increases Risk of Death

Hypertension-Related CV Deaths Surging Across the US

Mental Stress-Induced Ischemia Increases Risk of Poor Outcomes Post-MI

Potent Antithrombotic Therapy Cuts Spontaneous MI After PCI for ACS

Habitual Use of Fish Oil Prevents CVD, Real-world Data Suggest

Type 2 MI Linked to More CV Deaths, Even in Younger Patients

Poor Sleepers at Higher Risk of CVD, MESA Data Suggest

TCTMD’s Top 10 Most Popular Stories for February 2020

Meta-analysis Questions PCI vs CABG in Women With Multivessel Disease

Acute MI Symptom Clustering Differs in Men and Women: VIRGO

Outcome Differences Between Men and Women With PAD: EUCLID Insights

Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis

Trials of New Cancer Drugs Failing to Address Potential CV Risks

Association of Sex With Outcomes in Patients Undergoing PCI

Clopidogrel Interaction With Morphine in ACS Linked to More Ischemic Events

Revascularization After PCI or CABG Linked to Higher Mortality: EXCEL

Pricey, Unproven ‘Executive’ CVD Screening the Norm at Top US Hospitals

Lp(a) Reduction Contributes to Alirocumab’s Treatment Benefit: ODYSSEY Outcomes

CV Safety Trial for Lorcaserin Picks Up Cancer Signal: FDA

Survey Reveals Troubling Unawareness of Common MI Symptoms

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content